China fines British pharmaceutical firm for bribery
China has fined the giant pharmaceutical firm of the UK, GlaxoSmithKline (GSK), USD 490mn for bribing doctors and hospitals in order to have their products promoted.
The court gave its sentence after a one-day trial at a court in Changsha, China.
GSK’s former head of Chinese operations, Mark Reilly, received a suspended three-year prison and he is set to be deported. Other GSK executives have also been given suspended jail sentences.
The scandal has become the biggest corruption scandal to hit a foreign firm in years, with the company being alleged for having made an estimated USD 150mn in illegal profits.
GSK has published a statement of apology to the Chinese government and its people.
Related Articles
Officials Consider Cull as Chinese Car Industry Reaching Crisis Point
The automobile industry was once hailed as one of China’s greatest success stories. In less than a decade, China became
China’s Manufacturing Sector Picking Up Pace
According to an HSBC survey, China’s Purchasing Manager’s Index (PMI) rose to 49.5 in July, a five-month high and up
China and Japan to start direct yen-yuan trade in June
China will allow direct trading of the yuan and the Japanese yen, in a move aimed at promoting trade between
